OR (95% CI), per unit increase of parameter | ||
Subgroup/gender/parameter | Model 1 | Model 2 |
Patients with HCV infection | ||
Men (n=66) | ||
Body fat per cent | 1.75 (1.18 to 2.60)** | 6.11 (1.12 to 33.36)* |
Fat-free mass/BW, ×100 | 0.61 (0.45 to 0.84)** | 0.38 (0.18 to 0.82)* |
Muscle mass/BW, ×100 | 0.60 (0.43 to 0.84)** | 0.36 (0.16 to 0.81)* |
Women (n=45) | ||
Body fat per cent | 1.94 (1.30 to 2.91)** | 1.98 (1.29 to 3.04)** |
Fat-free mass/BW, ×100 | 0.51 (0.34 to 0.75)** | 0.48 (0.30 to 0.76)** |
Muscle mass/BW, ×100 | 0.50 (0.34 to 0.75)** | 0.47 (0.30 to 0.75)** |
Patients without HCV infection | ||
Men (n=711) | ||
Body fat per cent | 1.78 (1.61 to 1.96)*** | 2.46 (2.04 to 2.97)*** |
Fat-free mass/BW, ×100 | 0.58 (0.53 to 0.64)*** | 0.43 (0.36 to 0.52)*** |
Muscle mass/BW, ×100 | 0.58 (0.53 to 0.64)*** | 0.43 (0.36 to 0.51)*** |
Women (n=445) | ||
Body fat per cent | 2.17 (1.81 to 2.61)*** | 2.16 (1.78 to 2.61)*** |
Fat-free mass/BW, ×100 | 0.49 (0.42 to 0.58)*** | 0.49 (0.41 to 0.59)*** |
Muscle mass/BW, ×100 | 0.49 (0.41 to 0.58)*** | 0.48 (0.40 to 0.58)*** |
Model definitions are: Model 1, unadjusted analysis; Model 2, adjusted for age.
*p<0.05; **p<0.01; ***p<0.001.
BW, body weight.